MedPath

Ambispective Multicentric Study Evaluating UKA With U-Knee/Uni-Kroma Implants

Recruiting
Conditions
Unicompartmental Knee Arthroplasty
Registration Number
NCT05876143
Lead Sponsor
Societe dEtude, de Recherche et de Fabrication
Brief Summary

This clinical investigation was led as a post-market clinical follow-up study (post-market device development stage).The main objective of this study is to collect short- and medium-term clinical data on the unicondylar knee prosthesis U-Knee / Uni-Kroma, in order to evaluate the performance of these implants.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • All patients using a U-Knee / Uni-Kroma unicompartmental knee prosthesis and benefiting from the social security affiliation scheme.
Exclusion Criteria
  • Patients who objected to participating in the study and the processing of their data
  • Patients unable to understand the surgeon's instructions to complete their questionnaires or perform postoperative follow-up
  • Patients who already have a unicompartmental prosthesis on the knee in question that need to be revised.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival rate5 years

Assess the survival rate of the investigational medical devices at 5 year follow-up

Secondary Outcome Measures
NameTimeMethod
Functional improvementFrom pre-operative to 10 years

Evaluate pain, symptoms, activities of daily life and sports activity using KOOS score

ActivityFrom pre-operative to 10 years

Evaluate the degree of activity using Devane score

Survival rate12-18 months to 10 years

Assess the survival rate of the investigational medical devices at 12-18 months, 3 years and 10 years follow-up

Forgetfulness of prosthesisFrom pre-operative to 10 years

Evaluate the degree of forgetfulness of the prostheses using FJS- score

Trial Locations

Locations (1)

CHU Lyon Sud

🇫🇷

Pierre-Bénite, France

CHU Lyon Sud
🇫🇷Pierre-Bénite, France
Anthony Viste
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.